/N4P.L
N4P.L Stock - N4 Pharma Plc
Healthcare|Drug Manufacturers - Specialty & GenericLSE
$0.53+0.00%
+$0.00 (+0.00%) • Dec 22
66
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.44
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.58
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for N4P.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.52 – $0.53
TARGET (TP)$0.60
STOP LOSS$0.48
RISK/REWARD1:1.7
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.44
52W High$1.00
52W Low$0.35
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $7,282 | $1,953 | N/A | N/A | N/A |
| Gross Profit | $7,282 | $1,953 | N/A | N/A | N/A |
| Gross Margin | 100.0% | 100.0% | N/A | N/A | N/A |
| Operating Income | $-1,221,000 | $-1,425,000 | $-1,193,000 | $-1,843,000 | $-1,564,000 |
| Net Income | $-1,059,000 | $-1,269,000 | $-1,029,000 | $-1,544,000 | $-1,305,000 |
| Net Margin | -14542.7% | -64977.0% | N/A | N/A | N/A |
| EPS | $-0.00 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
Company Overview
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
N4P.LBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q3 2025
EPS Surprise History
Q2 21
No data
Q4 21
No data
Q2 22
No data
Q1 23
No data
Q3 23
No data
Q2 24
No data
Q3 24
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 25, 2025 | — | $-0.00 | — | — |
Q2 2025 | May 28, 2025 | — | — | — | — |
Q3 2024 | Sep 24, 2024 | — | $-0.00 | — | — |
Q2 2024 | Apr 23, 2024 | — | $-0.00 | — | — |
Q3 2023 | Sep 12, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 9, 2023 | — | $-0.00 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.00 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.00 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.00 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.00 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.00 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.01 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.00 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.01 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.00 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.03 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-0.00 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-0.00 | — | — |
Q4 2015 | Dec 31, 2015 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about N4P.L
What is N4P.L's current stock price?
N4 Pharma Plc (N4P.L) is currently trading at $0.53 per share. The stock has moved +0.00% today.
What is the analyst price target for N4P.L?
No analyst price targets are currently available for this stock.
What sector is N4 Pharma Plc in?
N4 Pharma Plc operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the LSE exchange.
What is N4P.L's market cap?
N4 Pharma Plc has a market capitalization of $0.00 billion, making it a small-cap company.
Does N4P.L pay dividends?
No, N4 Pharma Plc does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCHLL.L
Chill Brands Group PLC
$0.78
Mkt Cap: $0.4B
CRTX.L
CRISM Therapeutics Corporation
$9.50
Mkt Cap: $0.4B
FDBK.L
Feedback plc
$8.00
Mkt Cap: $0.4B
GDR.L
Genedrive Plc
$0.80
Mkt Cap: $0.5B
MHC.L
MyHealthChecked PLC
$8.75
Mkt Cap: $0.5B
OBD.L
Oxford BioDynamics Plc
$0.23
Mkt Cap: $0.5B
PRM.L
Proteome Sciences plc
$2.35
Mkt Cap: $0.7B
SUN.L
Surgical Innovations Group plc
$0.45
Mkt Cap: $0.4B
TCF.L
Theracryf Plc
$0.20
Mkt Cap: $0.4B
TRX.L
Tissue Regenix Group plc
$7.25
Mkt Cap: $0.5B
Explore stocks similar to N4P.L for comparison